Last $33.61 USD
Change Today -0.21 / -0.62%
Volume 33.6K
FMS On Other Exchanges
Symbol
Exchange
OTC US
Xetra
Munich
New York
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Else-Kröner Strasse 1

Bad Homburg, 61352

Germany

Phone: 49 6172 6090

Fax: 49 6172 609 2301

Fresenius Medical Care AG & Co. KGaA operates as a kidney dialysis company in the field of dialysis products and services worldwide. The company’s dialysis business is integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, it sells dialysis products to other dialysis service providers. In the U.S., it also provides inpatient dialysis services and other services under contract to hospitals. In 2013, the company provided 40,456,900 million dialysis treatments. The company also develops and manufactures a range of machines, systems, and disposable products, which it sells to customers in approximately 120 countries. Dialysis Care Dialysis Services The company provides dialysis treatment and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics, 2,133 of which are in the North America segment (including Mexico) and 1,117 of which are in approximately 45 countries outside of North America. At the company’s clinics, it provides hemodialysis (HD) treatments at individual stations through the use of dialysis machines and disposable products. A nurse attaches the necessary tubing to the patient and the dialysis machine and monitors the dialysis equipment and the patient's vital signs. As part of the dialysis therapy, the company provides various services to end stage renal disease (ESRD) patients at its dialysis clinics in the U.S. These services include administering erythropoietin (EPO), a synthetic engineered hormone that stimulates the production of red blood cells. EPO is used to treat anemia, a medical complication that ESRD patients frequently experience. The company administers EPO to majority of its patients in the U.S. Amgen Inc. is the sole manufacturer of EPO in the U.S. The company’s clinics also offer services for home dialysis patients, the majority of whom receive peritoneal dialysis (PD) treatment. For those patients, it provides materials, training, and patient support services, including clinical monitoring, follow-up assistance and arranging for delivery of the supplies to the patient's residence. The company also provides dialysis services under contract to hospitals in the U.S. on an ‘as needed’ basis for hospitalized ESRD patients and for patients suffering from acute kidney failure. It services these patients either at their bedside, using portable dialysis equipment, or at the hospital's dialysis site. Other Services Laboratory Services The company has full service laboratories that support the needs of its patients in the U.S. and also provides laboratory testing for others in the U.S. through Spectra Laboratories (Spectra). Spectra provides blood, urine, and other bodily fluid testing services to determine the appropriate individual dialysis therapy for a patient and to assist physicians in determining whether a dialysis patient's therapy regimen, diet, and medicines remain optimal. In 2013, Spectra acquired Shiel Laboratories (Shiel). Shiel expands the company’s laboratory services to include clinical anatomic pathology and molecular testing in the New York region. Pharmacy Services The company offers pharmacy services, primarily in the U.S. These services include delivering renal medications and supplies to the homes of patients or to their dialysis clinic directly from renal pharmacists who are primarily trained in treating and counseling patients living with kidney disease. It also supports education and compliance with phosphate binders and other medications for bone and mineral metabolism. Vascular Access Surgery Services The company has vascular access clinics primarily in the U.S. and also operates clinics in Portugal, as well as has opened a new clinic in Taiwan. Dialysis requires access to the bloodstream, which is accomplished by catheters, grafts, or arteriovenious fistulas. In addition, the vascular access centers provide services to address peripheral artery disease, which is common in dialysis patients. Dialysis Products The company manufactures and distributes equipment and related products for HD, as well as manu

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMS:US $33.61 USD -0.21

FMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $76.65 USD -0.35
CareFusion Corp $44.82 USD +0.08
DaVita HealthCare Partners Inc $71.46 USD -0.43
Terumo Corp ¥2,312 JPY -13.00
Toray Industries Inc ¥703.70 JPY +5.80
View Industry Companies
 

Industry Analysis

FMS

Industry Average

Valuation FMS Industry Range
Price/Earnings 18.7x
Price/Sales 1.4x
Price/Book 2.2x
Price/Cash Flow 19.1x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE-ADR, please visit www.fmc-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.